Mustang Bio MBIO
NASDAQ MBIO
$0.47 +0.00 (+0.58%)
As of: Oct 1, 2026 · 3:59 PM EDT

Mustang Bio (MBIO) Long-Term Debt Repayments (2016 - 2017)

Updated

Mustang Bio's Long-Term Debt Repayments came in at $30.38 million for FY2023.

Analysis

Mustang Bio (MBIO) Long-Term Debt Repayments (2016 - 2017) Analysis & Trends

Going back to FY2016, Mustang Bio's Long-Term Debt Repayments data covers 4 years.

  • Long-Term Debt Repayments carries a three-year compound annual growth rate of 24.5% (FY2020 to FY2023).
  • The FY2023 figure represents the lowest annual Long-Term Debt Repayments since FY2020.
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $15.75 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Mustang Bio 3.10 Mn 3.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 320,000.00
Dec 31, 2016 -1.53 Mn
Sep 30, 2016 3.53 Mn
API Access

Mustang Bio Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=MBIO&period=max&api_key=YOUR_API_KEY